V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330010197 | 330004535 | 1.75 | 80.6 | Curative (C) | 2018-04-28 | 2018-06-07 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330012373 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330010198 | 330004538 | 1.67 | 60 | Palliative (P) | null | 2017-04-20 | Cisplatin + Docetaxel +Fluorouracil | null | null | 330012378 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330010199 | 330010588 | 1.58 | 52 | Neo-adjuvant (N) | 2017-10-06 | 2017-10-07 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330012378 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330010200 | 330004542 | 1.8 | 67 | Curative (C) | 2014-04-06 | 2014-11-26 | VAI (Ifos 3g/m2) | 02 | N | 330012382 | VAI |
| 330010201 | 330004545 | null | 71.6 | Neo-adjuvant (N) | 2014-10-05 | 2014-11-07 | BENDAMUSTINE + RITUXIMAB | N | null | 330012393 | BENDAMUSTINE + RITUXIMAB |
| 330010202 | 330010590 | 1.69 | 69.2 | Palliative (P) | null | 2014-11-18 | ALL UKALL2011 Cap Int Maint C PAsp | Y | null | 330012397 | UKALL2011 |
| 330010203 | 330010591 | 1.66 | 76.8 | Palliative (P) | 2017-10-21 | 2017-11-17 | Paclitaxel (2 or 3 weekly) | 2 | N | 330012411 | PACLITAXEL |
| 330010204 | 330004549 | 1.75 | 36.8 | Adjuvant (A) | null | 2015-01-25 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 330012411 | PACLITAXEL |
| 330010205 | 330004551 | 1.82 | 53.2 | Palliative (P) | 2019-05-26 | 2019-07-10 | Paclitaxel (2 or 3 weekly) | N | N | 330012437 | PACLITAXEL |
| 330010206 | 330004555 | 1.62 | 42 | Curative (C) | 2017-10-15 | 2018-02-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330012450 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330010207 | 330004557 | 0 | 13.6 | Adjuvant (A) | 2017-11-02 | 2018-03-15 | CETUXIMAB + RT | 01 | N | 330012452 | CETUXIMAB + RT |
| 330010208 | 330004558 | null | null | Curative (C) | null | 2018-04-13 | VAI (Ifos 3g/m2) | N | null | 330012458 | VAI |
| 330010210 | 330004561 | 1 | 63.1 | Palliative (P) | 2018-03-15 | 2018-04-06 | CARBOPLATIN + PACLITAXEL | 02 | null | 330012476 | CARBOPLATIN + PACLITAXEL |
| 330010211 | 330008488 | null | 46.3 | Neo-adjuvant (N) | 2014-08-02 | 2014-10-17 | PACLITAXEL | N | null | 330012495 | PACLITAXEL |
| 330010212 | 330008488 | 1.85 | 89 | Adjuvant (A) | 2015-09-05 | 2015-09-06 | Paclitaxel (2 or 3 weekly) | N | N | 330012495 | PACLITAXEL |
| 330010213 | 330004564 | 1.6 | null | Curative (C) | 2013-08-23 | 2013-11-29 | ALL UKALL2011 Maintenance B3 | 2 | N | 330012504 | UKALL2011 |
| 330010214 | 330004566 | 1.78 | null | Neo-adjuvant (N) | 2014-01-07 | 2014-02-07 | EURAMOS TRIAL | 02 | N | 330012515 | EURAMOS TRIAL |
| 330010215 | 330008491 | 1.73 | 20.6 | Palliative (P) | null | 2015-04-07 | Paclitaxel (2 or 3 weekly) | 02 | N | 330012515 | PACLITAXEL |
| 330010216 | 330004567 | 1.8 | 67 | Not known (9) | 2018-10-11 | 2018-10-11 | Carboplatin + Paclitaxel (3 weekly) | 2 | null | 330012518 | CARBOPLATIN + PACLITAXEL |
| 330010217 | 330004568 | null | 80.6 | Neo-adjuvant (N) | 2014-08-31 | 2014-10-26 | PACLITAXEL | 02 | null | 330012532 | PACLITAXEL |
| 330010218 | 330004570 | 1.78 | 66.6 | Palliative (P) | 2016-02-24 | 2016-04-03 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330012539 | CARBOPLATIN + PACLITAXEL |
| 330010219 | 330004570 | 1.85 | 69.9 | Palliative (P) | 2017-06-24 | 2018-03-02 | Carbo F | 02 | N | 330012539 | CARBO + FLUOROURACIL |
| 330010220 | 330004572 | null | 19.7 | Neo-adjuvant (N) | 2013-10-18 | 2013-10-22 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 330012542 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330010221 | 330004574 | 1.78 | null | Palliative (P) | 2015-12-07 | 2016-03-30 | Bendamustine+Rituximab(Sub Courses) | N | N | 330012543 | BENDAMUSTINE + RITUXIMAB |
| 330010222 | 330004576 | 2 | 50 | Palliative (P) | 2018-03-13 | 2018-03-19 | BENDAMUSTINE + RITUXIMAB | null | N | 330012550 | BENDAMUSTINE + RITUXIMAB |
| 330010223 | 330004579 | 1.69 | 70 | Curative (C) | 2018-07-18 | 2018-07-18 | Carboplatin + Etoposide iv&po | 02 | N | 330012557 | CARBOPLATIN + ETOPOSIDE |
| 330010224 | 330004581 | 1.85 | 96.6 | Curative (C) | null | 2015-11-17 | BENDAMUSTINE + RITUXIMAB | N | N | 330012562 | BENDAMUSTINE + RITUXIMAB |
| 330010225 | 330004582 | 1.85 | 109.9 | Neo-adjuvant (N) | 2016-03-31 | 2016-07-08 | VAI (Ifos 3g/m2) | 2 | N | 330012563 | VAI |
| 330010226 | 330010601 | 1.75 | null | Palliative (P) | 2017-08-11 | 2017-08-27 | CARBOPLATIN + FLUOROURACIL | null | null | 330012591 | CARBO + FLUOROURACIL |
| 330010227 | 330004587 | 1.7 | 19.7 | Palliative (P) | 2017-06-03 | 2017-06-04 | ALL UKALL2011 Maintenance A1 | N | N | 330012594 | UKALL2011 |
| 330010228 | 330004590 | 1.7 | 14.9 | Palliative (P) | 2014-02-16 | 2014-02-16 | ALL UKALL2011 Maintenance C1 | 2 | N | 330012604 | UKALL2011 |
| 330010229 | 330004591 | 1.74 | 75.1 | Palliative (P) | 2013-07-07 | 2013-07-07 | Paclitaxel (2 or 3 weekly) | N | N | 330012606 | PACLITAXEL |
| 330010231 | 330004594 | 1.61 | 66.5 | Curative (C) | 2015-03-21 | 2015-04-14 | VAI (Ifos 3g/m2) | N | Y | 330012615 | VAI |
| 330010232 | 330004595 | 1.59 | null | Palliative (P) | 2016-04-14 | 2017-02-18 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 330012615 | PACLITAXEL |
| 330010233 | 330004596 | 1.7 | null | Palliative (P) | 2015-11-12 | 2015-11-17 | VAI (Ifos 3g/m2) | null | Y | 330012618 | VAI |
| 330010234 | 330004596 | 1.61 | 96 | Palliative (P) | 2016-09-27 | 2017-01-04 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330012618 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330010235 | 330004600 | 1.73 | 78.4 | Palliative (P) | null | 2019-02-18 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 330012634 | PACLITAXEL |
| 330010236 | 330004603 | 1.8 | 76 | null | 2014-07-27 | 2014-07-27 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 330012639 | BENDAMUSTINE + RITUXIMAB |
| 330010237 | 330004605 | 1.64 | 60 | Disease modification (D) | 2017-06-22 | 2017-06-27 | VAI (Ifos 3g/m2) | N | N | 330012642 | VAI |
| 330010239 | 330004610 | 1.8 | 74.9 | Palliative (P) | 2014-12-18 | 2015-01-22 | Paclitaxel (2 or 3 weekly) | N | Y | 330012653 | PACLITAXEL |
| 330010240 | 330004614 | 1.6 | 91.8 | Palliative (P) | 2017-09-23 | 2017-09-23 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 330012664 | CARBO + FLUOROURACIL |
| 330010241 | 330008514 | 0 | 60 | Palliative (P) | 2018-06-02 | 2018-06-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330012673 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330010242 | 330004616 | 1.6 | 63.6 | Palliative (P) | null | 2015-07-19 | EURAMOS TRIAL | Y | null | 330012677 | EURAMOS TRIAL |
| 330010243 | 330008516 | 1.7 | 81 | Palliative (P) | 2015-06-23 | 2015-11-18 | Cetuximab + Radiotherapy Load | 02 | N | 330012690 | CETUXIMAB + RT |
| 330010244 | 330008517 | 0 | 53.1 | Disease modification (D) | 2017-05-21 | 2017-05-24 | ALL UKALL2011 Del Int C Reind PAsp | 02 | N | 330012707 | UKALL2011 |
| 330010245 | 330004622 | null | 80 | Adjuvant (A) | 2014-02-01 | 2014-02-03 | CARBOPLATIN + RT | 02 | null | 330012713 | CARBOPLATIN + RT |
| 330010246 | 330004624 | 1.57 | 67.4 | Palliative (P) | 2010-11-02 | 2014-10-05 | Bendamustine+Rituximab (1st Course) | N | N | 330012718 | BENDAMUSTINE + RITUXIMAB |
| 330010247 | 330004625 | 1.73 | 63 | Palliative (P) | 2014-04-02 | 2014-04-04 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330012730 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330010248 | 330012814 | 1.6 | 53 | Palliative (P) | 2017-08-27 | 2017-08-28 | CARBOPLATIN + RT | 2 | N | 330012747 | CARBOPLATIN + RT |
| 330010249 | 330004628 | 0 | null | Palliative (P) | 2016-05-26 | 2016-05-26 | CARBOPLATIN + PACLITAXEL | N | N | 330012753 | CARBOPLATIN + PACLITAXEL |